Category Archives: Drugs

FDA Removes Black Box Warning On Smoking Cessation Medications

The FDA has determined that the risk of serious side effects on mood, behavior, or thinking with the smoking cessation medicines varenicline and bupropion is lower than previously suspected.  Following case reports of serious changes in mood and behavior in … Continue reading

Posted in Addiction, Drugs, Smoking cessation | Comments Off on FDA Removes Black Box Warning On Smoking Cessation Medications

Development and Regulation of Abuse-Deterrent Opioid Medications – FDA Public Meeting

The FDA is hosting a public meeting on October 30 and 31, 2014 to discuss the development, assessment, and regulation of abuse-deterrent formulations of opioid medications. The meeting will focus on scientific and technical issues related to the development and … Continue reading

Posted in Drugs, FDA, Opioids, Substance abuse | Comments Off on Development and Regulation of Abuse-Deterrent Opioid Medications – FDA Public Meeting

Sixth Annual Chair Summit Begins This Week

This week a Master Class for Neuroscience Development called the Chair Summit takes place in Tampa, FL (Sept 26-28, 2013). In the early days of medical training in Kos, students, trainees and medical colleagues would gather to discuss their cases … Continue reading

Posted in Addiction, ADHD, Antipsychotic medication, Anxiety Disorders, Biomarker, Bipolar Disorder, Cardiovascular Risk Factors, Chronic Pain, CME, Dementia, Depression, Diabetes, Diagnosis, Digital medicine, Drug Development, Drugs, DSM-5, Early intervention, Education, Food, Genetics, Guideline, Imaging, Maintenance of Certification, Measurement-based care, Medical Education, Mood, MRI, Multiple sclerosis, Negative symptoms, Neuroscience, Obesity, Opioids, PET, Practice guideline, Psychosis, PTSD, Research, Schizophrenia, Smoking cessation, Social media, Stroke, Substance abuse, Transcranial magnetic stimulation, Vascular dementia | Comments Off on Sixth Annual Chair Summit Begins This Week

New report sheds light on adolescent substance use

According to a report published yesterday by SAMHSA, the number of teenagers from age 12 to 17 smoke cigarettes on a average day is over three-quarters of a million. In addition, typically over a half-million smoked marijuana and almost a half-million drank … Continue reading

Posted in Adolescents, Drugs, Opioids, Substance abuse, Uncategorized | Comments Off on New report sheds light on adolescent substance use

FDA Offers Draft Guidance on Abuse-deterrent Opioids

The U.S. Food and Drug Administration today issued a draft guidance document to assist industry in developing new formulations of opioid drugs with abuse-deterrent properties. It describes the FDA’s current thinking about the studies that should be conducted to demonstrate … Continue reading

Posted in Addiction, Drugs, News, Opioids | Comments Off on FDA Offers Draft Guidance on Abuse-deterrent Opioids